THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Globe Editorial

An Rx for FDA reform

July 31, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

YESTERDAY'S HEARING in Washington on the diabetes drug Avandia and its links to heart attacks underscores the need for a reformed Food and Drug Administration -- one that is more committed to protecting patients than to being part of the profit pipeline of the pharmaceutical industry. Avandia is just the latest example of an FDA-approved drug or medical device that ... (Full article: 447 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass